mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.8 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.8 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.0095 |
0.8 |